Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The RANKL/RANK/OPG pathway.

Brendan F Boyce1, Lianping Xing

  • 1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY 14642, USA. brendan_boyce@urmc.rochester.edu

Current Osteoporosis Reports
|October 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

A RANKL<sup>+</sup>/CXCR4<sup>+</sup> B cell population accumulates in bone marrow and causes age-related osteoporosis in mice.

Bone research·2026
Same author

Lymphatic Vessels are Involved in Monosodium Urate Clearance and Resolution of Gouty Inflammation in Mice.

Journal of inflammation research·2026
Same author

Telocyte Deletion Associated With Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Lymph nodes-targeted nano-prodrug for precise B cell immunoregulation to prevent collagen-induced arthritis.

Biomaterials·2026
Same author

The Function of <i>Efhd1</i> <sup>+</sup> Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis.

bioRxiv : the preprint server for biology·2025

The RANKL/RANK/OPG system regulates bone mass by controlling osteoclast activity. This system is crucial for bone health and impacts other tissues, influencing conditions like medial calcification.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Endocrinology

Background:

  • The discovery of the RANKL/RANK/OPG system has significantly advanced understanding of osteoclast biology.
  • Osteoblasts and stromal stem cells express RANKL, binding to RANK on osteoclasts and precursors.

Purpose of the Study:

  • To review the critical roles of the RANKL/RANK/OPG system in bone homeostasis.
  • To explore the system's functions beyond bone, including lymph node formation and arterial calcification.

Main Methods:

  • Literature review of studies on the RANKL/RANK/OPG signaling pathway.
  • Analysis of the system's involvement in normal physiological processes and pathological conditions.

Main Results:

  • RANKL/RANK signaling governs osteoclast differentiation, activation, and survival.

Related Experiment Videos

  • Osteoprotegerin (OPG) inhibits RANKL, protecting against excessive bone resorption.
  • The RANKL/OPG ratio is a key determinant of bone mass.
  • RANKL/RANK signaling also impacts lymph node development and mammary gland function.
  • OPG plays a role in preventing medial calcification in arteries.

    • Conclusions:

    • The RANKL/RANK/OPG system is central to skeletal health and bone mass regulation.
    • This signaling pathway has diverse physiological roles in multiple organ systems.
    • Understanding this system offers insights into treating bone disorders and other conditions.